Jayanth Panyam
University of Minnesota-Twin Cities
H-index: 47
North America-United States
Top articles of Jayanth Panyam
Report of the 2023 AACP Council of Deans Taskforce on Pharmacy Research and Scholarship
2024/1/6
Jayanth Panyam
H-Index: 37
Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor‐Initiating Stem‐Like Cells
Advanced Science
2023/5
Characterizing antibody internalization for rational selection of ADC linker design
Cancer Research
2023/4/4
Jayanth Panyam
H-Index: 37
Sulfobutylether-β-cyclodextrin hydrogel microspheres delivering TLR 7/8 agonist for transarterial immunoembolization
Cancer Research
2023/4/4
Shubhmita Bhatnagar
H-Index: 10
David Ferguson
H-Index: 10
Thomas Griffith
H-Index: 34
Jayanth Panyam
H-Index: 37
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing
Materials Today Bio
2023/4/1
Antibody fragments for detecting cancer and methods of use
2023/6/20
Combination of STING and TLR 7/8 agonists as vaccine adjuvants for cancer immunotherapy
Cancers
2022/12/11
STING and TLR 7/8 Agonist combination can improve immune checkpoint blockade therapy efficiency
Cancer Research
2022/6/15
Impact of nanoengineering on redox regulation and CXCR4-mediated homing of mesenchymal stem cells
Cancer Research
2022/6/15
CD133-targeting silicate prodrug nanoparticles for effective cancer stem cell targeting
Cancer Research
2022/6/15
Ketamine and propofol admixture
2022/6/14
Cancer stem cells and strategies for targeted drug delivery
2021/10
Jin Cao
H-Index: 11
Shubhmita Bhatnagar
H-Index: 10
Jiawei Wang
H-Index: 47
Swayam Prabha
H-Index: 17
Jayanth Panyam
H-Index: 37
Single-chain variable fragment anti-CD133 antibodies and uses thereof
2021/8/24
Functionalized nanoparticles and methods of use thereof
2021/4/6
Encapsulation of Andrographolide in poly(lactide-co-glycolide) Nanoparticles: Formulation Optimization and in vitro Efficacy Studies
Frontiers in Bioengineering and Biotechnology
2021/2/18
Jayanth Panyam
H-Index: 37
Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
Scientific reports
2021/2/8
Augmented lung tumor infiltration of chemotherapeutics using synthetic antigen receptor-mesenchymal stem cells (SAR-MSCs)
Cancer Research
2020/8/15
Jayanth Panyam
H-Index: 37
Swayam Prabha
H-Index: 17
A novel terpenoid class for prevention and treatment of KRAS‐driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems
Molecular carcinogenesis
2020/8
TLR7/8 agonist-loaded nanoparticles augment NK cell-mediated antibody-based cancer immunotherapy
Molecular pharmaceutics
2020/5/8
Exploiting antibody biology for the treatment of cancer
2020/3
Jayanth Panyam
H-Index: 37
